13F Holdings
中文EN

MED MEDIFAST INC

Miscellaneous Food Preparations & Kindred Products · NYSE · SEC CIK 910329 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-30.3%
TTM net income YoY-16,572.6%
TTM EPS YoY-18,600.0%
Revenue 3-yr CAGR-37.4%
Net income 3-yr CAGR—

Margins

Gross margin69.2%
Operating margin-11.6%
Net margin-13.6%
FCF margin-1.3%
EBITDA margin-7.4%

Returns

ROE-20.7%
ROA-16.1%
ROIC (approx.)-23.2%
Asset turnover1.18x

Leverage & solvency

Liabilities / assets24.8%
Debt / equity0.00x
Current ratio4.82x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.00x
Accruals ratio-16.1%
Payout ratio—
Capex / revenue1.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$385.79M$602.46M$1.07B$1.60B$1.53B
Cost of revenue$110.60M$157.84M$296.20M$458.16M$398.49M
Gross profit$275.19M$444.62M$775.85M$1.14B$1.13B
R&D expense$4.30M$4.60M$4.60M$4.50M$4.40M
SG&A expense$289.40M$441.75M$649.45M$955.61M$911.36M
Operating income-$14.21M$2.88M$126.40M$184.81M$216.24M
Pretax income-$5.64M$3.79M$128.80M$184.06M$216.13M
Income tax$13.03M$1.70M$29.38M$40.49M$52.10M
Net income-$18.67M$2.09M$99.42M$143.57M$164.03M
EBITDA$29,000$15.59M$139.51M$195.79M$223.05M
EPS (basic)-1.700.199.1312.8214.01
EPS (diluted)-1.700.199.1012.7313.89
Dividends declared per share0.000.004.956.565.68
Weighted avg. shares (diluted)10.98M10.96M10.92M11.28M11.81M
Balance sheet
Cash & equivalents$89.30M$90.93M$94.44M$87.69M$104.18M
Short-term investments$77.97M$71.42M$55.60M$0$5.36M
Inventory$20.23M$42.42M$54.59M$118.86M$180.04M
Current assets$201.68M$214.40M$224.03M$222.78M$306.87M
PP&E, net$31.23M$37.53M$51.47M$57.19M$56.13M
Total assets$247.97M$284.21M$309.91M$316.21M$398.33M
Current liabilities$42.96M$64.16M$92.30M$140.89M$169.83M
Total liabilities$49.05M$74.10M$108.43M$161.17M$195.85M
Shareholders' equity$198.92M$210.11M$201.48M$155.04M$202.47M
Shares outstanding10.99M10.94M10.90M10.87M11.59M
Cash flow statement
Operating cash flow$6.86M$24.48M$147.66M$194.57M$94.55M
Capital expenditure$5.61M$7.45M$6.48M$16.68M$34.21M
Free cash flow$1.25M$17.02M$141.17M$177.89M$60.34M
Investing cash flow-$7.93M-$26.52M-$61.05M-$11.41M-$29.06M
Financing cash flow-$564,000-$1.51M-$79.79M-$199.58M-$125.13M
Depreciation & amortization$14.24M$12.71M$13.11M$10.98M$6.81M
Stock-based compensation$7.64M$7.36M$8.19M$11.05M$9.90M
Dividends paid$195,000$715,000$73.02M$71.62M$63.86M
Share buybacks$0$0$3.60M$126.44M$56.00M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.